Suchergebnisse - "Dong, Xiaoxian"

PubPharm (11)

1

Analysis of the difference in SLCO1B1 and APOE gene polymorphisms between Mongolian and Han populations

enthalten in: Pharmacogenomics | 2022

von Niu, R. | Guo, L. | Dong, X. | +4

2

Analysis of the difference inSLCO1B1andAPOEgene polymorphisms between Mongolian and Han populations

enthalten in: Pharmacogenomics | 2022

von Niu, R. | Guo, L. | Dong, X. | +4

3

Combined therapeutic effects of bortezomib and anacardic acid on multiple myeloma cells via activation of the endoplasmic reticulum stress response

enthalten in: Molecular medicine reports | 2016

von Dong, X. | Liao, Y. | Liu, N. | +4

4

A microRNA-mediated decrease in eukaryotic initiation factor 2α promotes cell survival during PS-341 treatment

enthalten in: Scientific reports | 2016

von Jiang, L. | Zang, D. | Yi, S. | +12

5

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth

enthalten in: Oncotarget | 2014

von Liu, N. | Li, X. | Huang, H. | +20

6

Gambogic acid is a tissue-specific proteasome inhibitor in vitro and in vivo

enthalten in: Cell reports | 2013

von Li, X. | Liu, S. | Huang, H. | +26

7

Sanggenon C decreases tumor cell viability associated with proteasome inhibition

enthalten in: Frontiers in bioscience (Elite edition) | 2011

von Huang, H. | Liu, N. | Zhao, K. | +18

8

Gambogic acid enhances proteasome inhibitor-induced anticancer activity

enthalten in: Cancer letters | 2011

von Huang, H. | Chen, D. | Li, S. | +14

9

Gambogic acid enhances proteasome inhibitor-induced anticancer activity

enthalten in: Cancer letters | 2011

von Huang, H. | Chen, D. | Li, S. | +13

10

Physiological levels of ATP negatively regulate proteasome function

enthalten in: Cell research | 2010

von Huang, H. | Zhang, X. | Li, S. | +16